Demeter, Lisa M <br/><br/>
Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience.  [electronic resource] 

 -  HIV clinical trials   
 - 11-25 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1528-4336 
<br/><br/><label>Standard No.: </label>10.1310/hct0901-11  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Alkynes<br/>Anti-HIV Agents--therapeutic use<br/>Benzoxazines--therapeutic use<br/>CD4 Lymphocyte Count<br/>Cyclopropanes<br/>Dideoxynucleosides--therapeutic use<br/>Double-Blind Method<br/>Drug Resistance, Viral<br/>Drug Therapy, Combination<br/>Female<br/>HIV Infections--drug therapy<br/>HIV Protease Inhibitors--therapeutic use<br/>HIV-1--drug effects<br/>Humans<br/>Indinavir--therapeutic use<br/>Male<br/>Middle Aged<br/>Treatment Outcome